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Background: The age-adjusted mortality rate in Israel is low compared to most Western countries although mortality
rates from diabetes and renal failure in Israel are amongst the highest, while those from cardiovascular diseases (CVD)
are amongst the lowest. This study aims to assess validity of choice of underlying causes (UC) in Israel by analyzing
Israeli and international data on the prevalence of these diseases as multiple causes of death (MCOD) compared to
UC, and data on comorbidity (MCOD based).
Methods: Age-adjusted death rates were calculated for UC and MCOD and the corresponding ratio of multiple to
underlying cause of death (SRMU) for available years between 1999 and 2012. Comorbidity was explored by calculating
cause of death association indicators (CDAI) and frequency of comorbid disease. These results were compared to data
from USA, France, Italy, Australia and the Czech Republic for 2009 or other available year.
Results: Mortality rates for all these diseases except renal failure have decreased in Israel between 1999 and 2012 as UC
and MCOD. In 2009, the SRMU for diabetes was 2.7, slightly lower than other Western countries (3.0–3.5) showing more
frequent choice as UC. Similar results were found for renal failure. In contrast, the SRMU for ischemic heart disease (IHD)
and cerebrovascular disease were 2.0 and 2.6, respectively, higher than other countries (1.4–1.6 and 1.7–1.9, respectively),
showing less frequent choice as UC. CDAI data showed a strong association between heart and cerebrovascular disease,
and diabetes in all countries. In Israel, 40 % of deaths with UC diabetes had IHD and 24 % had cerebrovascular disease.
Renal disease was less strongly associated with IHD.
Conclusion: This international comparison suggests that diabetes and renal failure may be coded more frequently in
Israel as UC, sometimes instead of heart and cerebrovascular disease. Even with some changes in coding, mortality rates
would be high compared to other countries, similar to the comparatively high diabetes prevalence in Israel at older ages
and high rate of end-stage renal failure.
This study highlights the importance of physician training on death certification practice and need for further progress
towards automation in recording and coding death causes.
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The age standardized mortality rate from all causes of
deaths is low in Israel compared to most OECD countries
[1], but the corresponding rates for deaths from diabetes
and kidney disease as underlying cause (UC) are amongst
the highest. In contrast, mortality rates from cardiovascu-
lar diseases (CVD), heart diseases and cerebrovascular
disease are low compared to other countries [1].
In accordance with international death certification
guidelines, the notification of death form in Israel in-
cludes the immediate cause of death, the train of events
that led to this cause and other significant diseases, con-
ditions or injuries that contributed to death but were
not directly related to the disease or condition causing
death. The Central Bureau of Statistics (CBS) chooses
the UC according to definitions and conventions of the
International Classification of Diseases (ICD) and has
coded it according to ICD-10 since 1998. Choice of UC
is manual, although in recent years occasional use has
been made of Iris, an automatic system for coding mul-
tiple causes of death and selection of the UC, in particu-
lar in cases where the UC is unclear. In addition, in
1999, 2003 and since 2007, all causes mentioned on the
notification of death form (multiple causes of death,
MCOD) have been coded by the CBS.
In many other countries, too, data on MCOD have be-
come available and analyzed in recent years. Redelings
et al. [2] published a comparison of underlying and mul-
tiple cause mortality in the USA in 2000–2001. A French
and Italian group of researchers, Desesquelles et al. [3],
developed two standard indicators which can be used to
analyze MCOD data and the mortality profiles they
present. They used these indicators to explore mortality
patterns in France and Italy, and published tables and
graphic representations. They also initiated a collection
of internationally comparable data for these indicators,
the Multicause Network [4], and workshops to discuss
use of MCOD data.
The Australian Institute of Health and Welfare also
published a detailed analysis of MCOD for chronic dis-
eases [5]. The USA has data available on MCOD from
the Centers for Disease Control and Prevention (CDC)
on the WONDER database [6]. Amongst other recent
studies using MCOD data were those estimating the
high burden of sepsis related mortality in England [7],
and the USA [8], and of diabetes in France [9] and
Finland [10]. Lu et al. [11] compared diabetes mortality
rates as UC and MCOD, and frequency of choice of
diabetes as UC and of diabetes in part 1 of the death
certificate, from all diabetes reported deaths, in
Taiwan, Australia and Sweden.
The problem of choosing diabetes as UC, in particular
when coexisting CVD are found, has also been raised by
Adair and Rao [12] who found an increasing ratio ofdiabetes with CVD in part I of the death certificate com-
pared to part II, in Australia, and to a lesser extent in
the USA, between 1999 and 2006. They suggest that this
may affect choice of UC and contribute to increasing
diabetes mortality rates, and point to the need for inter-
national guidelines on certifying deaths with diabetes
and CVD. Nojilana et al. [13] also wrote of the need for
such guidelines in view of wide country variations in the
proportion of diabetes related deaths with diabetes men-
tioned in part I of the death certificate.
This study presents recent mortality rates in Israel for
diabetes, renal failure and cardiovascular diseases as UC
and as MCOD. The study then investigates whether ana-
lysis of Israeli and international data on disease prevalence
found in MCOD compared to UC, and on comorbidity
from MCOD can validate the choice of UC in Israel. Are
the extremely high and low values due to coding practices,
such as choosing diabetes and kidney disease instead of
CVD as UC of death?
Methods
Israeli mortality data on underlying, and all contributory
causes of death was taken from the nationwide database
of causes of death prepared by the Central Bureau of
Statistics (CBS) with causes coded according to ICD-10.
MCOD data was available for the years 1999, 2003 and
2007–2012.
Desesquelles et al. [3], defined two standard indicators:
1. The Standardized Ratio of Multiple to Underlying
cause (SRMU), which is the ratio of the age standardized
mortality rate for any mention of a cause (from MCOD),
divided by the age standardized mortality rate for the
cause when chosen as underlying cause (UC). This ratio
reflects the frequency of mention of the cause on the
death certificate compared to its choice as underlying
cause, and is low for conditions usually selected as
underlying and high for those rarely chosen. 2. The
Cause of Death Association Indicator (CDAI), which is a
ratio of the proportion of a contributory cause among all
deaths chosen with a specific underlying cause to its
proportion among all deaths. The calculation of this
indicator uses standard death counts to enable inter-
national comparison (see formula in Table 2). This
indicator represents the frequency of occurrence of
underlying and contributory causes together, and when
significantly greater than 100 (with a 95 % confidence
interval over 100), shows a greater association than
would be expected randomly.
Age standardized mortality rates in Israel were calcu-
lated for the UC and MCOD, and the ratio of multiple
to underlying cause of death (SRMU) for available years
between 1999 and 2012 for the following diseases
(ICD-10 codes in parenthesis): diabetes (E10-E14), is-
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Fig. 1 Age-standardized underlying mortality rates in Israel, by causes of death, 1999–2012. Rates/100,000 population, age standardized
to 2013 European standard population
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cerebrovascular disease (I60-I69), and renal failure
(N17-N19). These diseases were chosen because of
their high or low rates in Israel compared to other
countries, availability of international data from the
Multicause Network, and their potential interchange-
ability as UC of death [12, 13]. We did not investigate
other causes which are often comorbid with diabetes
such as obesity, Alzheimer’s disease and dementia, and
skin diseases, since, according to WHO coding rules, they
should not be chosen as UC when listed with diabetes.
Age standardization was to the 2013 European standard
population.
The SRMU, CDAI and a 95 % confidence interval for














Fig. 2 Age-standardized multiple mortality rates in Israel, by causes o
2013 European standard populationby Desesquelles et al. [3, 4]. A 95 % confidence interval,
based on the standardized rates, was also calculated for
the SRMU. The mean number of causes per death
certificate, (excluding ill-defined causes) was also calcu-
lated, as this can be expected to affect the MCOD
indicator values.
Israeli results were compared with those from Italy [14],
France [15] and the USA [16] for 2009, and Czech data for
2011 [17], available from the Multicause Network [4], and
Australian values published for 2007 [5]. We used Czech
data for 2011 because it was coded after the introduction
of automatic coding with Iris and reported to be more
reliable and internationally comparable [18].
There was no need for ethical approval since the data
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Fig. 3 The Standardized Ratio of Multiple to Underlying mortality rates (SRMU), by causes of death, 1999–2012. Ratio of rates, age
standardized to 2013 European standard population
Table 1 Age-standardized mortality rates per 100,000 for underlying and multiple cause, Standardized Ratio of
Multiple to Underlying cause (SRMU) and average number of causes by country, selected causes of death, 2009a
Cause of death/country France Italy USA Czech Republic Australiab Israel
Standardized mortality rate for underlying cause (UC)
Diabetes 20 33 31 27 18 59
Ischemic heart disease 68 126 181 337 108 111
Other heart disease 74 68 58 70 N/A 37
Cerebrovascular disease 56 104 61 140 55 54
Renal Failure 12 15 20 8 10c 38
Total mortality 968 986 1100 1248 885d 920
Standardized mortality rate for multiple cause (MC)
Diabetes 60 117 106 169 61 159
Ischemic heart disease 109 200 257 551 174 227
Other heart disease 211 297 221 479 N/A 227
Cerebrovascular disease 97 194 102 245 96 142
Renal Failure 68 138 103 83 58 178
SRMU
Diabetes 3.0 3.5 3.4 6.2 3.4 2.7
Ischemic heart disease 1.6 1.6 1.4 1.6 1.6 2.0
Other heart disease 2.9 2.7 3.8 6.8 N/A 6.1
Cerebrovascular disease 1.7 1.9 1.7 1.8 1.8 2.6
Renal Failure 5.6 9.4 5.0 9.9 5.9c 4.7
Average number of causes (without ill defined) 2.5 3.3 2.6 3.1 3.1 3.5
Source of data: Italy [14], France [15], USA [16], Czech Republic [17]
Australia: Australian institute of Health and Welfare publication [5]
Total mortality – includes all causes of deaths
a Australia – 2007, unstandardized rates, Czech Republic – 2011
b Cause specific mortality rates for Australia are not standardized
c For chronic and unspecified renal failure (N18-N19), and for other countries N17-N19
d Standardized rate for 2009: Based on data downloaded from the Australian institute of Health and Welfare [35]
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France 450b 172b 230b
Italy 296b 108b 211b
USA 387b 162b 262b
Czech Republic 157b 99 149b
Israel 223b 144b 228b
Israel : % with MC
39.8 32.7 24.4
UC Renal failure
France 194b 183b 88
Italy 148b 118b 93
USA 140b 134b 86
Czech Republic 130 136b 63
Israel 143b 134b 96
Israel : % with MC
25.1 31.0 10.1
Source of data: Italy [14], France [15], USA [16], Czech Republic [17]











u = number of deaths observed at age x with underlying cause u and
contributing cause c
udx
u = number of deaths observed at age x with cause u as underlying cause
dc,x = total number of deaths observed at age x with cause c as contributing
cause (regardless of the underlying cause)
dx = total number of deaths observed at age x (regardless of the
underlying cause)
dx = standard number of deaths at age x (number of deaths from the 2009
WHO life table for high income countries)
aCzech Republic - 2011
b Significantly above 100 with 95 % CI calculated as specified in [4]
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Figures 1 and 2 show trends in standardized mortality
rates as UC and MCOD for diabetes, renal failure, IHD,
other heart disease and cerebrovascular diseases. All these
diseases, except renal failure, had steadily decreasing rates
both as UC and MCOD between 1999 and 2012. The
highest decrease, 51 %, was for IHD, 54 % as UC and 51 %
as a MCOD between 1999 and 2012. The rate of decrease
was similar for diabetes as UC and MCOD, 27 % and 30 %
respectively. Cerebrovascular disease and other heart dis-
ease showed a greater decrease as MCOD than UC. The
renal failure mortality rate increased by 25 % as UC, while
as MCOD, after an initial increase, it decreased to the
same rate in 2012 as 1999. The SRMU shown in Fig. 3 re-
flect the relative differences in change between MCOD
and UC. For IHD and diabetes the SRMU was relatively
stable over the years, although it decreased for all other
diseases. The SRMU for diabetes ranged between 2.3 and
2.9, and for cerebrovascular disease started at 3.0 in 1999,
but decreased over this period to 2.2 in 2012. The SRMU
for renal failure, also decreased by about 20 % from 5.5 to
4.4, while that for other heart disease had a relatively
smaller decrease from 6.7 to 5.9.
Table 1 shows, for selected causes of death, the age-
standardized mortality rates for underlying and multiple
causes, the SRMU and the average number of causes per
certificate for each country in this comparison. Israel has
the highest average number of causes per certificate and
France and the USA the lowest. In France a maximum
of 6 causes is allowed per certificate compared to 13 in
Italy [3], and 20 in the USA and Australia [5, 6]. In
Israel, where the certificates are not automated, the only
limit is the space on the form and a maximum of 16
causes was found.
Age standardized mortality rates for diabetes as UC
and MCOD were lowest in France and Australia, and
highest in Israel. The rate for IHD was very high in the
Czech Republic and in the USA and lowest in France.
The mortality rate for cerebrovascular disease was high-
est in the Czech Republic and also high in Italy. Other
heart disease was lowest in Israel, while renal failure was
highest in the Czech Republic and lowest in Australia.
The SRMU for diabetes and renal failure was lowest
in Israel, 2.7 (95 % CI 2.6–2.8) for diabetes, compared
to 3.0 in France, and 3.4–3.5 in Italy, USA and Australia
and 6.2 in the Czech Republic. The SRMU for renal fail-
ure was very high in Italy and the Czech Republic (9.5,
9.9) compared to Israel, 4.7 (95 % CI 4.4–4.9), and the
USA, France and Australia (5.0, 5.6, 5.9). The SRMU
for IHD and cerebrovascular disease, 2.0 (95 % CI 2.0–
2.1) and 2.6 (95 % CI 2.5–2.8) respectively, were higher
in Israel than other countries, particularly for cerebro-
vascular disease, 2.6 compared to 1.7–1.9. The SRMU
for other heart disease in Israel, 6.1 (95 % CI 5.7–6.4),was higher than all countries except the Czech
Republic.
Table 2 shows the CDAI indicator for diabetes and
renal failure as UC with contributing cause of IHD,
other heart disease and cerebrovascular disease. There
were significantly high associations of all the cardiovas-
cular causes with diabetes in all countries (95 % CI
above 100), except for other heart disease in the Czech
Republic and Italy. Values were particularly high for
IHD in France and the USA. Renal failure was also
significantly associated with IHD and other heart disease
in most countries, but not with cerebrovascular disease.
In Israel, this association can also be seen from the fact
that 40 % of those with diabetes and a quarter of those
with renal disease as UC had IHD as a contributory
cause. About a third of those with UC of diabetes and
renal disease had other heart disease as a contributory
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had cerebrovascular disease as a contributory cause.Discussion
The data we presented in Table 1 showed that the total
age-adjusted mortality rate in Israel was lower than France,
Italy, USA and the Czech Republic and higher than
Australia although Israel’s rank varied by cause of death.
We presented disease rates for these countries from
MCOD and comorbidity indicators, and asked whether
they could support the suggestion that differences in coding
practice, such as choice of UC of death or physician’s filling
in of death certificates leads to this distribution of UC.
Number of causes listed
The first question in the comparability of MCOD data is
how many causes are listed on death certificates. The low-
est average number found in France is consistent with the
low limit on number of causes in their certificate, but the
average number in the USA was similarly low, despite the
large number of causes allowed. Rates of mortality from
multiple causes listed, and corresponding SRMUs would
be expected to be higher in countries where more causes
are usually recorded as would be the case for Israel with
the highest mean number of causes.
Diabetes
In the case of diabetes, we found the SRMU in Israel to
be lower than other countries despite the higher average
number of causes. This would support the suggestion that
diabetes is chosen as UC more often. The low SRMU for
diabetes is also supported by the high association of
diabetes with CVD, frequently mentioned amongst mul-
tiple causes, as shown in Table 2 for all countries. In Israel,
diabetes as UC was found with IHD (40 % of cases), cere-
brovascular disease (33 %) and other heart disease (25 %).
Table 1 shows that the multiple mortality rate from
diabetes in Israel was higher than France, the USA, Italy
and Australia. Therefore, even if diabetes was chosen
less often as UC, as we saw in other Western countries
(SRMU = 3.0–3.5), the mortality rate as UC would still
be considerably higher than other countries.
It thus appears that the high mortality rate from dia-
betes is valid, although somewhat higher than it should
be by international standards.
Is this supported by prevalence rates of diabetes in
Israel? Although crude total diabetes prevalence in
Israel has not been reported as exceptionally high,
7.6 % in 2011 for adults aged 20–79, ranking slightly
above the OECD average of 6.9 % [19], a careful
comparison of recent data shows a somewhat different
picture. We received age specific data from the Inter-
national Diabetes Federation (IDF) from their recentlypublished update of diabetes prevalence in 2014 for
European countries. Israeli data was received from the
National Program for Quality Indicators in Community
Healthcare in Israel for 2014 [20]. This program col-
lects data from Health Funds, which provide universal
coverage to all citizens in Israel, and therefore should
give an accurate estimate, better than the survey based
IDF data. Results by age are shown in Additional file 1:
Figure S1).
We found that at young ages, Israel has one of the
lowest rates of diabetes prevalence amongst European
countries. However, for the intermediate age group of
the IDF, 40–59, Israel’s rank increased, and for the oldest
age group, 60–79, the prevalence in Israel is among the
highest, after Portugal (which had the next highest mor-
tality rate from diabetes amongst European countries
[1]). This further validates the high mortality rate.
Why is diabetes mortality so high in Israel? In the last
decade, there has been a heightened awareness in the
medical community of diabetes and treatment options
which may also lead to its frequent mention on death
certificates. There may be genetic differences in disease
susceptibility and in disease complication rates since
the genetic pool in Israel is a unique combination of
the many ethnic origins of its inhabitants. Lastly, per-
haps our higher rates of mortality from diabetes repre-
sent not an over-diagnosis of diabetes- caused death in
Israel, but rather an under-diagnosis in other countries.
For example, in a USA study of diabetics, diabetes was
recorded on only 41 % of the death certificates of dece-
dents, and chosen as UC for 13 %, leading to a consider-
able underestimate of the burden of disease [21].
It should be noted that the decreasing trend in the
mortality rate for diabetes in Israel which we saw in
Figs. 1 and 2 between 2003 and 2012 was the same for
diabetes as UC and as a MC, and the SRMU was also
relatively stable over the period, showing that there have
not been significant changes in certifying and coding
practice for diabetes in Israel. This is different from the
rates reported by Lin at el. in Taiwan [22], where the
trend in UC rates was different from the trend in
MCOD rates. Lin reported that the USA, like Israel, had
similar UC and MCOD trends.Renal failure
We saw in Table 1 the high rates of renal failure in Israel
both as UC and MCOD. We also saw that the SRMU
for renal failure is marginally lower than France,
Australia and the USA. Table 2 showed that ischemic
and other heart diseases were frequently found as associ-
ated causes both in Israel and other countries, but not
cerebrovascular disease. Here, too, it could be that renal
failure is chosen more frequently as UC than if should
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diseases.
Renal failure mortality includes both chronic and acute
renal failure. If chronic renal failure mortality is truly
high it should be reflected in chronic kidney disease
rates. OECD data for the prevalence rate in 2011 of end-
stage renal failure in Israel treated by dialysis or kidney
transplants does show Israel amongst the highest of
OECD countries, although well below that of the USA
([23], Additional file 2: Figure S2). A recent publication
by the Israeli Society of Nephrology and Hypertension
(ISNH) with the Israeli Center of Disease Control
(ICDC) [24] also shows very high incidence rates of new
patients receiving renal replacement therapy in 2009
compared to other countries, particularly at ages over 45
when Israeli rates were second highest, with only the
USA having higher rates.
Acute renal failure, however, is not connected to end-
stage renal disease. A recent WHO published document
notes that causes like renal failure are, in fact, “modes of
dying” rather than “causes of death” and therefore should
be reported with a precipitating cause, and not generally
listed as underlying cause at all [25]. A comparison of
acute and chronic renal failure mortality rates from the
European Detained Mortality Database [26], shows that
Israeli mortality rates are particularly high for acute renal
failure, about six times that of Western EU members (a
computed weighted average), compared to under three
times for chronic renal failure. These high rates could be
due to the certifying physician incorrectly listing acute
renal failure as UC of death.Cardiovascular diseases
Table 1 shows that the SRMU for cardiovascular diseases
was higher in Israel than other countries implying that
they were chosen as UC less often, but also reflecting
the higher average number of causes. Replacing diabetes
and renal failure with heart diseases as UC, as suggested
above, would lead to higher mortality rates for IHD and
other heart disease although the rates would still be low
relative to other Western countries. Similarly, cerebro-
vascular disease would replace some of the diabetes
mortality, but still remain low. We did note in Fig. 3 a
trend of decreasing SRMU for cerebrovascular disease,
from 3.0 in 1999 to 2.2 in 2012, nearer to that of other
countries, and indicating that it is already being coded
more frequently as UC.Health policy implications and future trends
Diabetes
Although we saw in Figs. 1, 2 and 3 decreasing mortality
rates from diabetes in recent years, both as UC and MC,
with a relatively stable SRMU, the rates are still well aboveother Western countries. We showed that some of the
excess may be due to differences in choosing UC, but it
remains a challenge to the health system in Israel to con-
tinue efforts to control this disease, both by treatment and
prevention. The recent OECD health care quality review
on Israel [27] reported diabetes care to be good and im-
proving in recent years, but noted a particularly high
prevalence among certain population groups, such as
Israeli-Arabs (constituting 20 % of the population) and
Ethiopian immigrants (constituting 1 % of the population),
who may have lower quality of care. The OECD review
also suggests that Israel should step up efforts to manage
diabetes complications and co-morbidities, and improve
care co-ordination.
Education in healthy living such as that promoted by
the inter-ministerial program for healthy and active liv-
ing [28], or by initiatives such as that reported by the
Clalit Health fund in the Sharon and Shomron area for
the Arab population, which organizes culturally attuned
programs for healthy living amongst Arab women [29],
are very important. We hope that these efforts will lead
to a lowering of mortality rates to the level of other
countries.
A hopeful trend is noted in a recent paper by Tomas
Karpati et al. [30] on the prevalence and incidence rates
of diabetes in the Clalit Health Fund, which insures
more than half the Israeli population. They reported that
although prevalence rates were rising steadily, in the last
few years the age standardized prevalence rate and rates
at younger ages have stabilized, while the incidence rate
actually decreased since 2006. This trend will hopefully
also lead to a reduction in mortality from diabetes.
Renal failure
Why is renal failure so high in Israel? Since diabetes
often leads to end-stage renal failure (ESRF), its high
prevalence in Israel at older ages contributes to the high
renal failure rates. This is supported by the high proportion
of diabetes among new patients receiving renal replacement
therapy (RRT) in Israel, which increased from 19 % in 1989
to 41 % in 2001 [30] and 43 % in 2009 [24]. We see from
the ISNH report [24] that this proportion was relatively
stable over the last decade, as was the incidence rate of new
RRT patients, after a steep increase during the 1990’s.
Calderon et al. [31] discuss other reasons for the high
rate of ESRF reported in Israel. They note that RRT is pro-
vided in Israel to all patients with ESRF with no official
age or comorbidity restrictions, and since 1995 the health
funds which provide insurance are reimbursed for dialysis
treatment. As well as high Israeli rates of incidence and
prevalence of chronic renal failure, there may be differ-
ences in progression rates from chronic renal failure to
ESRF. In addition, a large wave of immigrants came from
the Former Soviet Union (FSU) in the 1990’s, who were
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including renal disease, and now are about 10 % of the
Israeli population. The subsequent decrease in their immi-
gration in the last decade, as well as possible improvements
in diabetes and hypertension treatment may have led to the
stabilizing of the incidence and prevalence of ESRD, as well
as the decreasing trend in renal failure mortality as a
MCOD and to a lesser extent as UC, which we saw in Figs. 1
and 2. An improvement in certification practices may lead
to a reduction in the coding of acute renal failure as UC.
Death certification and coding practice
Our findings support the need for physicians to be
trained to fill in death notification forms correctly,
following international guidelines on determining the
true UC of death, and not the immediate symptoms, to
ensure correct international comparability of death mor-
tality data. Although amongst physicians’ routine duties,
death certification is not currently part of the medical
curriculum, and physicians are expected to learn on their
own, using an instructional pamphlet as a reference. The
Israel Health Ministry is embarking upon a web based
training program that might become compulsory for all
medical graduates.
Lu et al. [33] have raised another certification and
coding problem which can affect diabetes mortality
rates. Incorrect causal sequences on part I of the death
certificate, such as those with hypertension reported
after diabetes may lead to hypertension being reported
as UC instead of diabetes, particularly if coding rules are
not applied correctly. This, too, supports the need for
the physician training program mentioned above.
The coding of UC in the CBS is done manually by a
relatively small number of coders, so mistakes by one
coder can have significant and lasting effects on statistics.
The CBS administers an internal quality control process
in which a sample of one tenth of cases is coded twice
each year. A high level of agreement, 91–96 % of cases,
was found between 2007 and 2012. The CBS makes efforts
to encourage discussion and consultation between coders
to ensure uniformity and data valid for international
comparisons.
There are plans to automate the notification of death
form in Israel. This would limit the number of causes and
enable automatic choice of UC according to WHO coding
rules, using a computerized system such as ACME (Auto-
mated Classification of Medical Entities), which many
other countries have implemented. This could redress
some of the coding issues we found in this study and make
Israeli data more comparable internationally.
Israel has a high proportion of immigrant physicians. In
2013, 37 % of doctors under 65 were born in Eastern
Europe [34]. The somewhat limited knowledge of Hebrew
and English of these immigrants might also lead to errorsin completing the form. Automation plans mentioned
above should help this too, but in the meantime, a more
user-friendly death notification form with an English
translation, might help.
Limitations
Reference to MCOD data and indicators shows the
complexity of choosing the UC and how coding prac-
tices can differ among countries. The Czech Republic, in
contrast to Israel, rarely codes diabetes and renal failure
as UC as seen by the high SMRU. As life expectancy
increases and with it increased comorbidities, it becomes
harder to choose one UC and therefore international
comparisons based on UC only may be misleading.
The first limitation on the use of MCOD data is its avail-
ability. It would be useful if more countries provided their
MCOD data to a central database such as the MultiCause
Network [4]. Another problem is that the indicator values
are dependent on the number of causes, which varies
between countries. We expect the SRMU to be higher the
more causes are listed and the CDAI to be lower. We saw
in Table 2 that France and the USA with lowest number
of causes in general have higher CDAIs. Numerical
comparisons are therefore not possible with the current
indicator definitions.
Strict comparability between countries depends on
similar data collection and coverage. The highest age
group available in Israel for mortality data is 85 and over,
while the European Standard Population gives weights
for ages up to 95 and over. Grouping ages over 84 into
additional groups results in higher age-standardized
rates, affecting the comparison with Israel.
Conclusion
This international comparison suggests that diabetes and
renal failure may be coded more frequently in Israel as
UC and that they are coded instead of heart and cere-
brovascular disease. However, even with coding changes,
diabetes and renal failure mortality rates would be high
compared to other countries, similar to their high rate
as MCOD. The comparatively high diabetes prevalence
in Israel at older ages and the high rate of ESRF indicate
a need for improvement in prevention and care.
This study highlights the need for training physicians
on death certification practice and the importance of
further progress towards automation in recording and
coding death causes.
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